Surgery for non-small cell lung cancer in patients with a history of cardiovascular surgery

Maeda, Hideyuki; Kanzaki, Masato; Sakamoto, Kei; Isaka, Tamami; Yamazaki, Kenji; Onuki, Takamasa

doi:10.1007/s00595-016-1386-5

Cited by 3 publications

(1 citation statement)

References 31 publications

(29 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Surgery for patients with lung cancer who have previously undergone thoracic aortic replacement is expected to be difficult due to the reopening of the chest and adhesions present between the blood vessel prosthesis and the lung parenchyma. To date, there have been no comprehensive reports on performing anatomical lung resection for left lung cancer in these patients [1]. In this article, we report our experience with five such cases and discuss the pitfalls of performing lobectomy in these patients and the necessary precautions that should be taken.…”

Section: Introductionmentioning

confidence: 96%

Anatomical lung resection for left lung cancer after thoracic aortic replacement

Hayashi

Hanaoka

Ohshio

et al. 2021

Gen Thorac Cardiovasc Surg

View full text Add to dashboard Cite

After thoracic aortic replacement, extensive adhesions are expected to develop between the prosthesis and the lung. There have been no definitive reports on anatomical lung resection performed in patients with left lung cancer after thoracic aortic replacement. Herein, we report a series of five such cases. Our findings showed that severe adhesions were encountered after aortic arch and descending aortic replacement, but not after ascending aortic replacement. We think that these adhesions started developing in the early postoperative period and were particularly severe in the case of left upper lobe lung cancer after arch replacement. However, anatomical lobectomy and systematic lymph node dissection could still be performed safely by devising a surgical technique. In addition, there was a possibility that a new aortic aneurysm may have occurred at the time of surgery. Therefore, it is important to perform a thorough preoperative evaluation and coordinate with the cardiovascular surgery department.

show abstract

Section: Introductionmentioning

confidence: 96%

Anatomical lung resection for left lung cancer after thoracic aortic replacement

Hayashi

Hanaoka

Ohshio

et al. 2021

Gen Thorac Cardiovasc Surg

View full text Add to dashboard Cite

show abstract

Concomitant Coronary Artery Disease and Lung Cancer

Mistiaen

2020

Cardiac Surgery

View full text Add to dashboard Cite

Preoperative Management of Patients With Cardiovascular Diseases for Elective Cancer Surgery

Сумин

2019

Kompleks. probl. serdečno-sosud. zabol.

View full text Add to dashboard Cite

Significant progress in the diagnosis and treatment of cancer resulted in a marked improvement in the survival of these patients. Declining mortality in acute cardiovascular diseases is accompanied by an increase in the proportion of patients with chronic cardiovascular pathology. Both trends resulted in a growing cohort of patients with concomitant oncology and cardiovascular disease, given rise to cardiooncology, a rapidly growing field. Cardio-oncology incudes a variety of clinical issues, particularly preoperative assessment of patients for cancer surgery. However, this section has been recently neglected in the recent guidelines. This review focuses on the preoperative management of patients with cardiovascular diseases for elective cancer surgeries. It reports the existing algorithm of assessing the risk of cardiac events in non-cardiac surgeries relatively to cancer patients. Current international and national guidelines were published in 2014 and, therefore, do not contain the latest evidences. Thus, this review summarizes all recent data and provides a modified and simplified preoperative management strategy for cancer patients. In particular, surgical risk assessment should be comprehensive, taking into account the complexity of the surgical procedures and the severity of comorbidity. The review discusses specific risk assessment scales proposed for different groups of cancer patients (for example, the ThRCRI scale in surgeries for non-small cell lung cancer). In addition, it contains various options for assessing the functional status of patients (stress tests, including spiroergometry, DASI index, assessment tables). Current recommendations on additional screening and preventive treatment of patients are summarized and addressed to the healthcare specialists and researchers studying perioperative risk assessment in cancer surgery.

show abstract

Surgery for non-small cell lung cancer in patients with a history of cardiovascular surgery

Cited by 3 publications

References 31 publications

Anatomical lung resection for left lung cancer after thoracic aortic replacement

Anatomical lung resection for left lung cancer after thoracic aortic replacement

Concomitant Coronary Artery Disease and Lung Cancer

Preoperative Management of Patients With Cardiovascular Diseases for Elective Cancer Surgery

Contact Info

Product

Resources

About